HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Equity Capital Markets

Dental Doctor Medical Holding Group / Equity Capital Markets

<ul>
<li>Dental Doctor has not established core competitiveness and high moat, and has to invest more on marketing and promotion to attract customers and drive growth.</li>
<li>The lack of dentists, weak talent and training system as well as high dentist turnover rate would be big concerns for the Company’s long term development, especially for nationwide expansion.</li>
<li>This industry has not yet entered the profit mode. Most of chain dental services providers are still in the stage of cash-burning expansion. So, we are conservative about the Company’s outlook.</li>
</ul>


Dental Doctor has not established core competitiveness and high moat, and has to invest more on marketing and promotion to attract customers and drive growth.
The lack of dentists, weak talent and training system as well as high dentist turnover rate would be big concerns for the Company’s long term development, especially for nationwide expansion.
This industry has not yet entered the profit mode. Most of chain dental services providers are still in the stage of cash-burning expansion. So, we are conservative about the Company’s outlook.


Pre-IPO Dental Doctor Medical Holding Group - An Uncertain Outlook and Concerns About Profitability

Equity Bottom-Up

<ul>
<li>Arrial's positioning at high-end private dental chain indicates limited growth space. The large investment in dental professionals drags down overall margins but fails to generate good word-of-mouth and expected returns.</li>
<li>Public hospitals with NRDL reimbursement and private dental chains with high cost performance would put more pressure on Arrail. Increasing marketing/promotion expenses cannot turn things around but further reduce margins.</li>
<li>Overall, the high-end strategy cannot bring high-end returns. We are not optimistic about Arrail's prospects and profitability. The Company may even keep losing money and hard to turn profitable.</li>
</ul>


Arrial's positioning at high-end private dental chain indicates limited growth space. The large investment in dental professionals drags down overall margins but fails to generate good word-of-mouth and expected returns.
Public hospitals with NRDL reimbursement and private dental chains with high cost performance would put more pressure on Arrail. Increasing marketing/promotion expenses cannot turn things around but further reduce margins.
Overall, the high-end strategy cannot bring high-end returns. We are not optimistic about Arrail's prospects and profitability. The Company may even keep losing money and hard to turn profitable.


Arrail Group (6639.HK) - The Development Strategy Cannot Generate High Returns

China

Dental Doctor Medical Holding Group (DDM HK)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Dental Doctor Medical Holding Group (DDM HK)

Pre-IPO Dental Doctor Medical Holding Group - An Uncertain Outlook and Concerns About Profitability

Dental Doctor hasn't established core competitiveness.The lack of dentists/low profitability hinder expansion.As a reliable profit model hasn't...

Xinyao (Criss) Wang

Arrail Group (6639.HK) - The Development Strategy Cannot Generate High Returns

Arrail's development strategy cannot generate high returns, with limited growth space.High labor cost and marketing/promotion expense drag down...

Xinyao (Criss) Wang

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)